nodes	percent_of_prediction	percent_of_DWPC	metapath
Masoprocol—CYP19A1—Betamethasone—multiple sclerosis	0.379	0.632	CbGbCtD
Masoprocol—CYP19A1—Dexamethasone—multiple sclerosis	0.22	0.368	CbGbCtD
Masoprocol—IGF1R—brainstem—multiple sclerosis	0.0081	0.132	CbGeAlD
Masoprocol—Isoprenaline—MAPK1—multiple sclerosis	0.00699	1	CrCbGaD
Masoprocol—IGF1R—nervous system—multiple sclerosis	0.00424	0.069	CbGeAlD
Masoprocol—IGF1R—central nervous system—multiple sclerosis	0.00409	0.0665	CbGeAlD
Masoprocol—IGF1R—cerebellum—multiple sclerosis	0.00399	0.065	CbGeAlD
Masoprocol—LTB4R—brain—multiple sclerosis	0.00393	0.0639	CbGeAlD
Masoprocol—CYP2J2—medulla oblongata—multiple sclerosis	0.00383	0.0623	CbGeAlD
Masoprocol—CYP2J2—midbrain—multiple sclerosis	0.0035	0.0569	CbGeAlD
Masoprocol—CYP2J2—spinal cord—multiple sclerosis	0.00341	0.0555	CbGeAlD
Masoprocol—IGF1R—brain—multiple sclerosis	0.00324	0.0528	CbGeAlD
Masoprocol—CYP2J2—nervous system—multiple sclerosis	0.00288	0.0468	CbGeAlD
Masoprocol—CYP2J2—central nervous system—multiple sclerosis	0.00277	0.0451	CbGeAlD
Masoprocol—CYP2J2—cerebellum—multiple sclerosis	0.00271	0.044	CbGeAlD
Masoprocol—ALOX5—nervous system—multiple sclerosis	0.00227	0.0369	CbGeAlD
Masoprocol—CYP2J2—brain—multiple sclerosis	0.0022	0.0358	CbGeAlD
Masoprocol—ALOX5—central nervous system—multiple sclerosis	0.00218	0.0355	CbGeAlD
Masoprocol—ALOX5—cerebellum—multiple sclerosis	0.00213	0.0347	CbGeAlD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.002	0.00601	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.002	0.00601	CbGpPWpGaD
Masoprocol—IGF1R—Plasma membrane estrogen receptor signaling—MMP9—multiple sclerosis	0.00196	0.0059	CbGpPWpGaD
Masoprocol—CYP19A1—FSH signaling pathway—BDNF—multiple sclerosis	0.00195	0.00589	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—IL4—multiple sclerosis	0.00195	0.00586	CbGpPWpGaD
Masoprocol—IGF1R—SHC-related events triggered by IGF1R—IL6—multiple sclerosis	0.00181	0.00545	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—IFNG—multiple sclerosis	0.00177	0.00532	CbGpPWpGaD
Masoprocol—ALOX5—brain—multiple sclerosis	0.00173	0.0282	CbGeAlD
Masoprocol—CYP19A1—Ovarian Infertility Genes—VDR—multiple sclerosis	0.00167	0.00504	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—GPR65—multiple sclerosis	0.00166	0.00501	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—TLR4—multiple sclerosis	0.00161	0.00486	CbGpPWpGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.0016	0.00481	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—IL2—multiple sclerosis	0.00157	0.00473	CbGpPWpGaD
Masoprocol—CYP19A1—nervous system—multiple sclerosis	0.00157	0.0255	CbGeAlD
Masoprocol—LTB4R—Spinal Cord Injury—ICAM1—multiple sclerosis	0.00155	0.00466	CbGpPWpGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.00154	0.00465	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CCR1—multiple sclerosis	0.00152	0.00458	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CXCL13—multiple sclerosis	0.00152	0.00458	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—ITGA4—multiple sclerosis	0.00152	0.00457	CbGpPWpGaD
Masoprocol—CYP2J2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00152	0.00457	CbGpPWpGaD
Masoprocol—CYP19A1—central nervous system—multiple sclerosis	0.00151	0.0245	CbGeAlD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.0015	0.00452	CbGpPWpGaD
Masoprocol—CYP19A1—Endogenous sterols—POMC—multiple sclerosis	0.0015	0.00452	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.00142	0.00429	CbGpPWpGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.00139	0.00417	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—CCL2—multiple sclerosis	0.00138	0.00417	CbGpPWpGaD
Masoprocol—IGF1R—Endochondral Ossification—MMP9—multiple sclerosis	0.00137	0.00413	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00137	0.00412	CbGpPWpGaD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—TYK2—multiple sclerosis	0.00134	0.00403	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—CYP27B1—multiple sclerosis	0.00133	0.00401	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—CYP24A1—multiple sclerosis	0.00133	0.00401	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.00132	0.00398	CbGpPWpGaD
Masoprocol—CYP19A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00131	0.00396	CbGpPWpGaD
Masoprocol—CYP19A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00131	0.00396	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—TYK2—multiple sclerosis	0.0013	0.00393	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00129	0.00388	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	0.00126	0.00379	CbGpPWpGaD
Masoprocol—CYP2J2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.00123	0.0037	CbGpPWpGaD
Masoprocol—CYP19A1—brain—multiple sclerosis	0.0012	0.0195	CbGeAlD
Masoprocol—IGF1R—TSH signaling pathway—STAT3—multiple sclerosis	0.00119	0.00359	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00119	0.00358	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—IFNG—multiple sclerosis	0.00118	0.00354	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00117	0.00351	CbGpPWpGaD
Masoprocol—IGF1R—Endochondral Ossification—TGFB1—multiple sclerosis	0.00113	0.00341	CbGpPWpGaD
Masoprocol—IGF1R—Integrins in angiogenesis—MAPK1—multiple sclerosis	0.00112	0.00338	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.00112	0.00338	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00111	0.00336	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00111	0.00336	CbGpPWpGaD
Masoprocol—IGF1R—TSH signaling pathway—MYC—multiple sclerosis	0.00111	0.00333	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—IFNG—multiple sclerosis	0.0011	0.00331	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.00109	0.00328	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CCL3—multiple sclerosis	0.00108	0.00326	CbGpPWpGaD
Masoprocol—IGF1R—TSH signaling pathway—MAPK1—multiple sclerosis	0.00108	0.00326	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—SPP1—multiple sclerosis	0.00108	0.00325	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00107	0.00322	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—S1PR1—multiple sclerosis	0.00106	0.00319	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—IL1B—multiple sclerosis	0.00105	0.00316	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—IL2—multiple sclerosis	0.00105	0.00315	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—PTGER4—multiple sclerosis	0.00104	0.00314	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CXCR3—multiple sclerosis	0.00101	0.00303	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000993	0.00299	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000993	0.00299	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—RGS1—multiple sclerosis	0.000991	0.00298	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—MMP9—multiple sclerosis	0.00099	0.00298	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—STAT3—multiple sclerosis	0.000982	0.00296	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CCR2—multiple sclerosis	0.00098	0.00295	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—IL1B—multiple sclerosis	0.00098	0.00295	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.000973	0.00293	CbGpPWpGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000968	0.00291	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—GPR65—multiple sclerosis	0.00094	0.00283	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—IL6—multiple sclerosis	0.000922	0.00278	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00092	0.00277	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—MYC—multiple sclerosis	0.000912	0.00275	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—multiple sclerosis	0.00091	0.00274	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—MAPK1—multiple sclerosis	0.00091	0.00274	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—ALB—multiple sclerosis	0.000907	0.00273	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CNR1—multiple sclerosis	0.000904	0.00272	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—RGS1—multiple sclerosis	0.0009	0.00271	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—MAPK1—multiple sclerosis	0.000893	0.00269	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CCR1—multiple sclerosis	0.000859	0.00259	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000859	0.00259	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—GPR65—multiple sclerosis	0.000853	0.00257	CbGpPWpGaD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—MAPK1—multiple sclerosis	0.000852	0.00257	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—TNF—multiple sclerosis	0.00085	0.00256	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—TNF—multiple sclerosis	0.00085	0.00256	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—MAPK1—multiple sclerosis	0.00083	0.0025	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000829	0.0025	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.000828	0.00249	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—LINGO1—multiple sclerosis	0.000825	0.00248	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—MYC—multiple sclerosis	0.000818	0.00246	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—TGFB1—multiple sclerosis	0.000816	0.00246	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CXCL10—multiple sclerosis	0.000814	0.00245	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—MAPK1—multiple sclerosis	0.0008	0.00241	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CXCL13—multiple sclerosis	0.00078	0.00235	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CCR1—multiple sclerosis	0.00078	0.00235	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000778	0.00234	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—TNF—multiple sclerosis	0.000762	0.00229	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—TGFB1—multiple sclerosis	0.000761	0.00229	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—MAPK1—multiple sclerosis	0.000747	0.00225	CbGpPWpGaD
Masoprocol—CYP19A1—FSH signaling pathway—MAPK1—multiple sclerosis	0.000746	0.00225	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—IL1B—multiple sclerosis	0.000738	0.00222	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TAGAP—multiple sclerosis	0.000715	0.00215	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—SRM—multiple sclerosis	0.000705	0.00212	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—LINGO1—multiple sclerosis	0.000702	0.00211	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CCL5—multiple sclerosis	0.000701	0.00211	CbGpPWpGaD
Masoprocol—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000696	0.0021	CbGpPWpGaD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—IL6—multiple sclerosis	0.000655	0.00197	CbGpPWpGaD
Masoprocol—CYP2J2—Biological oxidations—POMC—multiple sclerosis	0.000653	0.00197	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000648	0.00195	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—IL6—multiple sclerosis	0.000638	0.00192	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000634	0.00191	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CCR5—multiple sclerosis	0.000631	0.0019	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—SRM—multiple sclerosis	0.000628	0.00189	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—S1PR1—multiple sclerosis	0.000625	0.00188	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—IL6—multiple sclerosis	0.000615	0.00185	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—GPC5—multiple sclerosis	0.000608	0.00183	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TAGAP—multiple sclerosis	0.000608	0.00183	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000589	0.00178	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—IL6—multiple sclerosis	0.000574	0.00173	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000569	0.00171	CbGpPWpGaD
Masoprocol—CYP19A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000564	0.0017	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CCL3—multiple sclerosis	0.000556	0.00167	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CCR2—multiple sclerosis	0.000554	0.00167	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—TNF—multiple sclerosis	0.000536	0.00161	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PTGER4—multiple sclerosis	0.000535	0.00161	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—MAPK1—multiple sclerosis	0.000533	0.00161	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—RGS1—multiple sclerosis	0.000532	0.0016	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—S1PR1—multiple sclerosis	0.000532	0.0016	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—GPC5—multiple sclerosis	0.000517	0.00156	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CXCR3—multiple sclerosis	0.000517	0.00156	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000512	0.00154	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000512	0.00154	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CNR1—multiple sclerosis	0.000511	0.00154	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—GPR65—multiple sclerosis	0.000504	0.00152	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CCR2—multiple sclerosis	0.000503	0.00151	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP24A1—multiple sclerosis	0.000496	0.00149	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP27B1—multiple sclerosis	0.000496	0.00149	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000495	0.00149	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—POMC—multiple sclerosis	0.000493	0.00149	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000485	0.00146	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CCL2—multiple sclerosis	0.000483	0.00145	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—MAPK1—multiple sclerosis	0.000465	0.0014	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CNR1—multiple sclerosis	0.000464	0.0014	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CXCL13—multiple sclerosis	0.000461	0.00139	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCR1—multiple sclerosis	0.000461	0.00139	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00046	0.00139	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GPC5—multiple sclerosis	0.000454	0.00137	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—RGS1—multiple sclerosis	0.000452	0.00136	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP27B1—multiple sclerosis	0.000442	0.00133	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP24A1—multiple sclerosis	0.000442	0.00133	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000432	0.0013	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—IL6—multiple sclerosis	0.000432	0.0013	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—GPR65—multiple sclerosis	0.000429	0.00129	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CXCL10—multiple sclerosis	0.000418	0.00126	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GPC5—multiple sclerosis	0.000405	0.00122	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CCL5—multiple sclerosis	0.000396	0.00119	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CXCL13—multiple sclerosis	0.000392	0.00118	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCR1—multiple sclerosis	0.000392	0.00118	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.00038	0.00115	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—RRM1—multiple sclerosis	0.000376	0.00113	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CCL5—multiple sclerosis	0.00036	0.00108	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CCR5—multiple sclerosis	0.000357	0.00107	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000352	0.00106	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—RRM1—multiple sclerosis	0.000335	0.00101	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCL3—multiple sclerosis	0.000328	0.000989	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CCR5—multiple sclerosis	0.000324	0.000976	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SRM—multiple sclerosis	0.000323	0.000974	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—IL2RA—multiple sclerosis	0.000319	0.000962	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PTGER4—multiple sclerosis	0.000316	0.000952	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PGR—multiple sclerosis	0.000311	0.000938	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CXCR3—multiple sclerosis	0.000305	0.00092	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CD28—multiple sclerosis	0.000302	0.000911	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—POMC—multiple sclerosis	0.0003	0.000903	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCR2—multiple sclerosis	0.000297	0.000895	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000292	0.000879	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCL3—multiple sclerosis	0.000279	0.000841	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—POMC—multiple sclerosis	0.000279	0.00084	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CNR1—multiple sclerosis	0.000274	0.000826	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PTGER4—multiple sclerosis	0.000269	0.00081	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PGR—multiple sclerosis	0.000265	0.000797	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.00026	0.000783	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CXCR3—multiple sclerosis	0.00026	0.000782	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CD28—multiple sclerosis	0.000257	0.000775	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—POMC—multiple sclerosis	0.000253	0.000763	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCR2—multiple sclerosis	0.000253	0.000761	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000251	0.000755	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CCL2—multiple sclerosis	0.000248	0.000746	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CXCL10—multiple sclerosis	0.000247	0.000743	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CNR1—multiple sclerosis	0.000233	0.000702	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000229	0.000688	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP27B1—multiple sclerosis	0.000228	0.000686	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP24A1—multiple sclerosis	0.000228	0.000686	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—TYK2—multiple sclerosis	0.000225	0.000678	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000223	0.000673	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000223	0.000671	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—BCHE—multiple sclerosis	0.000216	0.000651	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CD86—multiple sclerosis	0.000216	0.00065	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCL5—multiple sclerosis	0.000212	0.00064	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CXCL10—multiple sclerosis	0.00021	0.000632	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GPC5—multiple sclerosis	0.000208	0.000628	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—IL2—multiple sclerosis	0.000206	0.000621	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000204	0.000614	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SPP1—multiple sclerosis	0.000197	0.000593	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—BCHE—multiple sclerosis	0.000193	0.00058	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	0.000192	0.000579	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCR5—multiple sclerosis	0.000191	0.000576	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL2RA—multiple sclerosis	0.000189	0.000568	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	0.000188	0.000567	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—IL2—multiple sclerosis	0.000187	0.000564	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CD86—multiple sclerosis	0.000184	0.000553	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCL5—multiple sclerosis	0.000181	0.000544	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—APOE—multiple sclerosis	0.000174	0.000524	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—RRM1—multiple sclerosis	0.000173	0.00052	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SPP1—multiple sclerosis	0.000167	0.000504	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCR5—multiple sclerosis	0.000163	0.00049	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL2RA—multiple sclerosis	0.00016	0.000483	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CD80—multiple sclerosis	0.000157	0.000474	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—POMC—multiple sclerosis	0.00015	0.000451	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—APOE—multiple sclerosis	0.000148	0.000446	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCL2—multiple sclerosis	0.000146	0.000441	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—MAPK1—multiple sclerosis	0.000143	0.000431	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000134	0.000404	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CD80—multiple sclerosis	0.000134	0.000403	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TYK2—multiple sclerosis	0.000133	0.0004	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—APOE—multiple sclerosis	0.00013	0.000391	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—POMC—multiple sclerosis	0.000127	0.000383	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCL2—multiple sclerosis	0.000124	0.000375	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—APOE—multiple sclerosis	0.000116	0.000349	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000115	0.000347	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TYK2—multiple sclerosis	0.000113	0.00034	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—POMC—multiple sclerosis	0.000112	0.000336	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL2—multiple sclerosis	0.000111	0.000333	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—IL6—multiple sclerosis	0.00011	0.000331	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000105	0.000316	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MMP9—multiple sclerosis	0.000105	0.000315	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ALB—multiple sclerosis	0.000102	0.000307	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—POMC—multiple sclerosis	9.95e-05	0.0003	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—BCHE—multiple sclerosis	9.92e-05	0.000299	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL2—multiple sclerosis	9.4e-05	0.000283	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—STAT3—multiple sclerosis	9.31e-05	0.00028	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ALB—multiple sclerosis	9.07e-05	0.000273	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MMP9—multiple sclerosis	8.9e-05	0.000268	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MYC—multiple sclerosis	8.65e-05	0.00026	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TGFB1—multiple sclerosis	8.63e-05	0.00026	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MAPK1—multiple sclerosis	8.46e-05	0.000255	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—STAT3—multiple sclerosis	7.91e-05	0.000238	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MYC—multiple sclerosis	7.35e-05	0.000221	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TGFB1—multiple sclerosis	7.34e-05	0.000221	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MAPK1—multiple sclerosis	7.19e-05	0.000217	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL6—multiple sclerosis	6.5e-05	0.000196	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—APOE—multiple sclerosis	5.97e-05	0.00018	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL6—multiple sclerosis	5.53e-05	0.000166	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—POMC—multiple sclerosis	5.13e-05	0.000154	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ALB—multiple sclerosis	4.67e-05	0.000141	CbGpPWpGaD
